SCHEMBL18633832

SCHEMBL18633832

C=C1/C=C(C(C)(C)O)\C=C/COCC2NC=CC=C2/C1=C\CCN1CC[C@@H](N(CC=O)Cc2ccc(Cl)cc2NCC)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16312655 0.82 CCR1 (0.33) —
SCHEMBL18895959 0.72 CCR1 (0.34) —
SCHEMBL18895955 0.66 CCR1 (0.38) —
SCHEMBL18896011 0.63 CCR1 (0.37) —
SCHEMBL18633826 0.62 CHRM2 (0.39) —
SCHEMBL18895954 0.59 CCR1 (0.37) —
SCHEMBL18633836 0.59 CCR1 (0.33) —
SCHEMBL13824459 0.58 CCR1 (0.40) —
SCHEMBL14579858 0.58 — —
SCHEMBL18895961 0.58 CCR1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1688418-B1 Chemokine receptor antagonists and methods of use thereof MILLENNIUM PHARM INC (US) 2017-03-15 — — EP disclosed
Send feedback